相关实验视频
Updated: Sep 19, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
作为扩散性皮肤全身性硬化症的潜在管理选择的阿巴达西丁:一个病例报告
Sidra Sarfaraz1, Janis Chang1, Mark G Kirchhof1
1Division of Dermatology, Department of Medicine, The Ottawa Hospital, Ottawa, ON, Canada.
系统性硬化症 (SSc) 是一种复杂的自身免疫性疾病. 一个对upadacitinib的试验显示,严重的,耐治疗的SSc.患者的血管和皮肤症状显著改善.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 系统性硬化症 (SSc) 是一种多系统的自身免疫性疾病,其特征是血管病变,免疫功能障碍和纤维化.
- SSc呈现出各种不同的临床表现,使治疗标准化复杂化,并影响多个器官.
- 扩散皮肤SSc (dcSSc) 涉及显著的皮肤加厚,并可能导致严重的并发症.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
Cystic Fibrosis: Management
Sinus disease and chronic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
The JAK-STAT Signaling Pathway